Search Results for "Skin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Skin. Results 31 to 40 of 438 total matches.

Linezolid (Zyvox)

   
The Medical Letter on Drugs and Therapeutics • May 29, 2000  (Issue 1079)
-susceptible Streptococcus pneumoniae, and skin and skin structure infections, including those due ...
Linezolid, the first of a new class of antibiotics, the oxazolidinones, has been marketed for treatment of infection due to vancomycin-resistant Enterococcus faecium, nosocomial and community-acquired pueumonia due to Staphylococcus aureus or penicillin-sucsceptible Streptococcus pneumoniae, and skin and skin structure infections, including those due to methicillin-resistant S. aureus (MRSA).
Med Lett Drugs Ther. 2000 May 29;42(1079):45-6 |  Show IntroductionHide Introduction

A New Sunscreen Agent

   
The Medical Letter on Drugs and Therapeutics • May 20, 2007  (Issue 1261)
) RADIATION — Solar UV radiation capable of injuring the skin is classified by wavelength into UVA1 (340-400 ...
Ecamsule (terephthalylidene dicamphor sulfonic acid), the first new sunscreen agent to be approved by the FDA in 18 years, is now available in the US in a moisturizer called Anthelios SX. Ecamsule has been used in Canada and Europe for more than 10 years.
Med Lett Drugs Ther. 2007 May 20;49(1261):41-3 |  Show IntroductionHide Introduction

Shade UVAGuard - A Second Broad-Spectrum Sunscreen

   
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993  (Issue 898)
) is the major cause of sunburn and chronic skin injury, including photoaging and skin cancer, and contributes ...
In 1989, Photoplex (Allergan Herbert), a combination of the dibenzoyl methane avobenzone (Parsol 1789) and the aminobenzoic acid (PABA) ester padimate O, was the first 'broad spectrum' sunscreen to become available in the USA (Medical Letter, 31:59, 1989). Now, Shade UVAGuard (Schering-Plough), a similar product, has been approved by the US Food and Drug Administration; it also contains avobenzone, plus the benzophenone oxybenzone and octyl methoxycinnamate.
Med Lett Drugs Ther. 1993 Jun 11;35(898):53-4 |  Show IntroductionHide Introduction

Tigecycline (Tygacil)

   
The Medical Letter on Drugs and Therapeutics • Sep 12, 2005  (Issue 1217)
and skin and skin-structure infections. It is the first of a new class of antibiotics called ...
Tigecycline (Tygacil - Wyeth), a derivative of minocycline, is a new intravenous (IV) antibiotic approved for treatment of complicated intra-abdominal and skin and skin-structure infections.
Med Lett Drugs Ther. 2005 Sep 12;47(1217):73-4 |  Show IntroductionHide Introduction

Quinupristin/Dalfopristin

   
The Medical Letter on Drugs and Therapeutics • Nov 19, 1999  (Issue 1066)
by vancomycinresistant Enterococcus faecium (VREF), and for treatment of complicated skin and skin structure infections ...
Quinupristin and dalfopristin, two streptogramin antibacterials marketed in a 30:70 combination as Synercid, have received accelerated approval from the FDA for intravenous treatment of bacteremia and life-threatening infection....
Med Lett Drugs Ther. 1999 Nov 19;41(1066):109-10 |  Show IntroductionHide Introduction

Tattoo Removal

   
The Medical Letter on Drugs and Therapeutics • Nov 24, 2003  (Issue 1170)
removal of all pigments with restoration of normal skin color and texture is not always possible (M ...
While more people than ever are getting tattoos, many come to regret their decision and would like to have them removed. The technology of removing tattoos is much better than it used to be, but still far from perfect. Complete removal of all pigments with restoration of normal skin color and texture is not always possible (M Kuperman-Beade et al, Am J Clin Dermatol 2001; 2:21; GM Lipper and RR Anderson in IM Freedberg et al, eds, Fitzpatrick's Dermatology in General Medicine 6th ed, New York:McGraw-Hill 2003, page 2508).
Med Lett Drugs Ther. 2003 Nov 24;45(1170):95-6 |  Show IntroductionHide Introduction

Testosterone Topical Solution (Axiron) for Hypogonadism

   
The Medical Letter on Drugs and Therapeutics • Jul 11, 2011  (Issue 1368)
of hypogonadism at baseline or after treatment. ADVERSE EFFECTS — Skin reactions at the site of application ...
The Medical Letter recently reviewed a topical gel formulation of testosterone (Fortesta) for treatment of hypogonadism in men. A topical testosterone replacement product for application to the axilla, Axiron (Lilly) solution, has now become available for the same indication. This site of application presumably minimizes the risk of transferring the drug to a family member or sexual partner.
Med Lett Drugs Ther. 2011 Jul 11;53(1368):54-5 |  Show IntroductionHide Introduction

Calcipotriene for Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 1994  (Issue 928)
sheets and clothing as well as skin. Resistant disease can be controlled with photochemotherapy (PUVA ...
Calcipotriene ointment 0.005% (calcipotriol; Dovonex - Westwood Squibb), a synthetic vitamin D 3 analog previously available in Europe and Canada, has now been approved by the US Food and Drug Administration (FDA) for treatment of moderate plaque psoriasis, the most common form of the disease.
Med Lett Drugs Ther. 1994 Aug 5;36(928):70-1 |  Show IntroductionHide Introduction

Drugs for Common Bacterial Infections in Adults

   
The Medical Letter on Drugs and Therapeutics • Oct 23, 2017  (Issue 1532)
respiratory, skin, and urinary tract infections are listed in Tables 1-3. Infectious disease experts now ...
Bacterial infections in adults are generally treated empirically, with the antibiotic covering most, but not all, of the potential causative pathogens. For some infections, culture and sensitivity testing can guide treatment, allowing for use of narrower-spectrum antibiotics. The recommended dosages and durations of antibiotic treatment for common respiratory, skin, and urinary tract infections are listed in Tables 1-3. Infectious disease experts now recommend shorter treatment durations for many infections to reduce the development of antimicrobial resistance and minimize adverse...
Med Lett Drugs Ther. 2017 Oct 23;59(1532):171-7 |  Show IntroductionHide Introduction

Ingenol Mebutate (Picato) for Actinic Keratoses

   
The Medical Letter on Drugs and Therapeutics • Apr 30, 2012  (Issue 1389)
of the Euphorbia peplus plant, a traditional folk remedy for warts and other skin lesions. ACTINIC KERATOSES ...
The FDA has approved ingenol mebutate (Picato – Leo) for topical treatment of actinic keratoses (AKs). The new drug is derived from the sap of the Euphorbia peplus plant, a traditional folk remedy for warts and other skin lesions.
Med Lett Drugs Ther. 2012 Apr 30;54(1389):35-6 |  Show IntroductionHide Introduction